Literature DB >> 8536190

Referral criteria for growth screening.

J A Hulse1.   

Abstract

Population height screening studies performed over the past 20 years have shown that between 17 and 21% of children with heights below the third centile have organic disease, of whom about 20% will be new diagnoses. The likelihood of organic disease increases to 50% for children with heights below -3 SDs. The age of screening will also influence the outcome as both acquired disease and disorders with progressive growth slowing, such as Turner's syndrome, are more likely to be detected by screening at an older age. Height velocity as a screening tool has evoked interest for many years as, despite technical problems, slowly growing children are thought more likely to have disease. Inclusion of height or height/weight relations may further improve screening sensitivity. It may assist in the early detection of coeliac disease or eating disorders in older children. A minimum of three measurements is required to define an individual's growth pattern and, preferably, five or six measurements spread over the preschool and primary school years. The value of extension of growth screening to the secondary school age group remains uncertain. Children should be screened for both height and weight and referred when there are major discrepancies between these two measurements (more than three centile bands). A two level system of referral with a community assessment for some children and a direct referral to a growth clinic for children with more severe growth disturbance may be the best use of resources.

Entities:  

Mesh:

Year:  1995        PMID: 8536190     DOI: 10.1177/096914139500200315

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  3 in total

1.  Identifying very fat and very thin children: test of criterion standards for screening test.

Authors:  J Mulligan; L D Voss
Journal:  BMJ       Date:  1999-10-23

2.  Short stature: an ordinary sign for an unordinary diagnosis.

Authors:  Paolo Cavarzere; Valentina Bortolotti; Michela Capogna; Margherita Guarnieri; Francesca Lucca; Rossella Gaudino; Stefano Marzini; Claudia Banzato; Franco Antoniazzi
Journal:  Ital J Pediatr       Date:  2017-07-28       Impact factor: 2.638

3.  Growth disorders in children and adolescents affected by syndromes or diseases associated with neurodysfunction.

Authors:  Lidia Perenc; Agnieszka Guzik; Justyna Podgórska-Bednarz; Mariusz Drużbicki
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.